G Medical Innovations ECG Patch receives FDA EUA for use in COVID-19 patients

G Medical Innovations recently announced that it received FDA emergency use authorization for its vital signs monitoring system ECG patch for remote monitoring of patients who are being treated for COVID-19.

The patch monitors the QT interval of an ECG in patients to watch for fatal arrhythmias that may occur from treatment drugs. Prolonged QT intervals could indicate a rhythm disorder in the heart, according to the company. The condition can lead to fainting, seizures or sudden death.

“This authorization from the FDA is an outstanding development for G Medical and its value cannot be underestimated. It is heartening to see that our technology has been recognized as being able to help ease the burden of COVID-19 on the US healthcare system,” CEO Yacov Geva said in a news release.

Under the emergency use authorization, the FDA said that “there is no adequate, approved and available alternative to the emergency use of the VSMS Patch for r…

Read more
  • 0